The "personalized cancer vaccines" (PCVs) used by the nine patients in the trial were targeted to genes specific to their ...

A personalized neoantigen cancer vaccine generated strong immune responses in renal cell carcinoma patients, leading to ...

After their advanced kidney tumors were surgically removed, nine patients were protected from the cancer returning thanks to ...

Researchers evaluated a neoantigen-targeting personalized cancer vaccine in patients with high-risk, fully resected clear ...

In the latest study, researchers found the main genetic mutations in renal cell cancer, possibly by using artificial intelligence (AI). The scientists injected mRNA vaccine made against proteins ...

Neoantigen-targeting personalized cancer vaccines (PCVs) are highly immunogenic in high-risk clear cell renal cell carcinoma (RCC) and can target key driver mutations and induce antitumor immunity, ...

Vaccines generated using the cells left over after tumour removal surgery could help to keep patients from redeveloping ...

A new report explores the disproportionately high death rate among Black women in the Delta from cervical cancer.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. We get into more ...

DES MOINES — State funding for the Double up Food Bucks Program, which provides a one-to-one match to Supplemental Nutrition ...

During health secretary nominee Robert F. Kennedy Jr.'s Jan. 29 Senate confirmation hearing, Sen. Elizabeth Warren, D-Mass., ...